Emboline, Inc., a privately held medical technology company developing embolic protection solutions for structural heart procedures, today announced positive results from its pivotal PROTECT H2H ...
Seacoast letter writers push back on the wage gap, say Kittery council isn’t listening on Dennett Road, warn about guns at ...
BACKGROUND: Medically tailored meals (MTM) have unanswered implementation questions. Providing MTM for a specific individual, ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation and what we’re reading from around the web. This week, ...
Tristan H. Cockcroft takes a look at five pitchers who are likely to be on many a fantasy championship roster.
Statistical significance achieved with new high dose-combination despite small sample size; Results validate dose selection ...
AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research sessionAcross the COAST 1, ...
Arletta Pharma announces positive results from phase II CDU study of Lybrido combination targeting female sexual dysfunction: Amsterdam, the Netherlands Monday, March 30, 2026, 16 ...
Each additional hour of active sitting lowered dementia risk by 4%. Substituting one hour of passive TV time with one hour of ...
The current crisis highlights the sad longevity of the toxic combination of hubris, power and corruption the control of oil ...
Inference is reshaping data center architecture, introducing a new and less forgiving set of network requirements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results